| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.21 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |